Predemtec
Predemtec focuses on the research, development and manufacture of innovative diagnostic tests for use in the detection of dementia-related risk factors. The first product, the Predemtec DX test, is a serum-based immunoassay and uses analysis algorithms for the early detection and risk diagnosis of senile dementia (Alzheimer’s type, AD).
Press releases
Press
Predemtec GmbH receives seed financing from High-Tech Gruenderfonds for developing a blood test to diagnose Alzheimer`s Disease
Predemtec GmbH in Hennigsdorf develops a blood test for a reliable diagnosis of Alzheimer's disease. In July 2014 the start-up received a seed financing from High-Tech Gruenderfonds (HTGF). The seed investment will be used to finalize the first test into a marketable product and to expand the scope of the test towards early diagnosis.
There are approximately 36 million patients worldwide suffering from dementia. With two thirds of all cases, Alzheimer's disease (AD) is the most frequent form
Info & Contact
Address
St. Gallerstrasse 99
9200 Gossau SG
Schweiz
9200 Gossau SG
Schweiz
In portfolio
27. May 2014